{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:14:23Z","timestamp":1790007263739,"version":"4.0.1"},"reference-count":157,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.revmed.2019.12.003","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T09:21:07Z","timestamp":1578388867000},"page":"168-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Complications de la maladie de Still de l\u2019adulte"],"prefix":"10.1016","volume":"41","author":[{"given":"M.","family":"Fauter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gerfaud-Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Delplanque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jamilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2019.12.003_bib0790","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12969-015-0047-3","article-title":"Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity","volume":"13","author":"Nirmala","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1\u20132","key":"10.1016\/j.revmed.2019.12.003_bib0795","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","article-title":"Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart","volume":"61","author":"Jamilloux","year":"2015","journal-title":"Immunol Res"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib0800","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.revmed.2014.10.365","article-title":"Donn\u00e9es actualis\u00e9es sur la physiopathologie, les ph\u00e9notypes et les traitements de la maladie de Still de l\u2019adulte","volume":"36","author":"Gerfaud-Valentin","year":"2015","journal-title":"Rev Med Interne"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib0805","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib0810","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1297-319X(02)00409-8","article-title":"Ferritin levels in adult Still's disease: any sugar?","volume":"69","author":"Fautrel","year":"2002","journal-title":"Jt Bone Spine Rev Rhum"},{"key":"10.1016\/j.revmed.2019.12.003_bib0815","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","article-title":"Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis","volume":"169","author":"Inoue","year":"2016","journal-title":"Clin Immunol Orlando Fla"},{"issue":"11","key":"10.1016\/j.revmed.2019.12.003_bib0820","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2019.12.003_bib0825","article-title":"Validation of the Fautrel classification criteria for adult-onset Still's disease","author":"Lebrun","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib0830","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib0835","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57\u00a0patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib0840","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","article-title":"Life-threatening complications of adult-onset Still's disease","volume":"33","author":"Efthimiou","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.revmed.2019.12.003_bib0845","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3899\/jrheum.161286","article-title":"Application of the 2016\u00a0EULAR\/ACR\/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease","volume":"44","author":"Ahn","year":"2017","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.revmed.2019.12.003_bib0850","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3899\/jrheum.170955","article-title":"Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort","volume":"45","author":"Ruscitti","year":"2018","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib0855","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62\u00a0patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib0860","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13054-018-2012-2","article-title":"Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review","volume":"22","author":"N\u00e9el","year":"2018","journal-title":"Crit Care Lond Engl"},{"issue":"9927","key":"10.1016\/j.revmed.2019.12.003_bib0865","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib0870","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(85)80072-X","article-title":"Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection","volume":"106","author":"Hadchouel","year":"1985","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib0875","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib0880","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/03009740310000148","article-title":"Bone marrow findings in patients with adult Still's disease","volume":"32","author":"Min","year":"2003","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"10.1016\/j.revmed.2019.12.003_bib0885","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jbspin.2013.04.011","article-title":"Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease","volume":"80","author":"Banse","year":"2013","journal-title":"Jt Bone Spine Rev Rhum"},{"issue":"11","key":"10.1016\/j.revmed.2019.12.003_bib0890","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/art.39295","article-title":"Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome","volume":"67","author":"Cifaldi","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"13","key":"10.1016\/j.revmed.2019.12.003_bib0895","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18\u00a0diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib0900","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.revmed.2015.10.348","article-title":"[Syndrome d\u2019activation macrophagique sous tocilizumab: mythe ou r\u00e9alit\u00e9\u00a0?.]","volume":"37","author":"Deroux","year":"2016","journal-title":"Rev Med Interne"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib0905","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.semarthrit.2017.06.006","article-title":"Adult onset Still's disease-The evidence that anti-interleukin-1\u00a0treatment is effective and well-tolerated (a comprehensive literature review)","volume":"47","author":"Junge","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib0910","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3899\/jrheum.140288","article-title":"Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab","volume":"42","author":"Yokota","year":"2015","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib0915","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","article-title":"Adult-onset Still disease","volume":"22","author":"Fautrel","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.revmed.2019.12.003_bib0920","doi-asserted-by":"crossref","first-page":"2071815","DOI":"10.1155\/2016\/2071815","article-title":"Adult Onset Still's Disease Associated with Mycoplasma pneumoniae Infection and Hemophagocytic Lymphohistiocytosis","volume":"2016","author":"Agnihotri","year":"2016","journal-title":"Case Rep Med"},{"issue":"11","key":"10.1016\/j.revmed.2019.12.003_bib0925","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362\u00a0patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"12","key":"10.1016\/j.revmed.2019.12.003_bib0930","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2005.046904","article-title":"Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature","volume":"65","author":"Arlet","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib0935","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MD.0b013e3181caf100","article-title":"Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8\u00a0patients","volume":"89","author":"Hot","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib0940","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/14397595.2014.974881","article-title":"Nationwide epidemiological survey of 169\u00a0patients with adult Still's disease in Japan","volume":"25","author":"Asanuma","year":"2015","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib0945","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-018-4114-1","article-title":"Are the 2016\u00a0EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?","volume":"39","author":"Tada","year":"2019","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.revmed.2019.12.003_bib0950","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","article-title":"Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245\u00a0patients","volume":"35","author":"Sfriso","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2019.12.003_bib0955","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2016.02.010","article-title":"Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort","volume":"69","author":"Kalyoncu","year":"2016","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib0960","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.11368","article-title":"Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review","volume":"49","author":"Dhote","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.revmed.2019.12.003_bib0965","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.semarthrit.2015.11.002","article-title":"Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature","volume":"45","author":"Lenert","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib0970","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bjh.13102","article-title":"Prognostic factors of early death in a cohort of 162\u00a0adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide","volume":"168","author":"Arca","year":"2015","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib0975","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/pbc.21441","article-title":"The role of hemophagocytosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Gupta","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib0980","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib0985","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.23415","article-title":"Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome","volume":"58","author":"Fardet","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib0990","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib0995","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.revmed.2019.12.003_bib1000","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib1005","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/art.38672","article-title":"Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults","volume":"66","author":"Kumakura","year":"2014","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"24","key":"10.1016\/j.revmed.2019.12.003_bib1010","doi-asserted-by":"crossref","first-page":"e6656","DOI":"10.1097\/MD.0000000000006656","article-title":"Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8mg\/kg\/d) of anakinra","volume":"96","author":"Parisi","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.revmed.2019.12.003_bib1015","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s10067-018-4095-1","article-title":"Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature","volume":"37","author":"S\u00f6nmez","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1086\/685112","article-title":"An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature","volume":"6","author":"Mehta","year":"2016","journal-title":"Pulm Circ"},{"key":"10.1016\/j.revmed.2019.12.003_bib1025","first-page":"3717392","article-title":"Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra","volume":"2016","author":"Kumar","year":"2016","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.revmed.2019.12.003_bib1030","first-page":"2345","article-title":"Interleukin 1\u00a0inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety","volume":"8","author":"Hong","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.revmed.2019.12.003_bib1035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fphar.2017.00369","article-title":"Response to Interleukin-1\u00a0Inhibitors in 140\u00a0Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study","volume":"8","author":"Colafrancesco","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.revmed.2019.12.003_bib1040","doi-asserted-by":"crossref","first-page":"5656320","DOI":"10.1155\/2016\/5656320","article-title":"Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease: A Case-Based Review","volume":"2016","author":"Watanabe","year":"2016","journal-title":"Case Rep Med"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10067-012-2105-2","article-title":"Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence","volume":"32","author":"de Boysson","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"25","key":"10.1016\/j.revmed.2019.12.003_bib1050","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","article-title":"Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18\u00a0and interleukin-6","volume":"58","author":"Shimizu","year":"2012","journal-title":"Cytokine"},{"issue":"23","key":"10.1016\/j.revmed.2019.12.003_bib1060","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib1065","first-page":"252","article-title":"Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy","volume":"7","author":"Stern","year":"2001","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"7","key":"10.1016\/j.revmed.2019.12.003_bib1070","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.revmed.2019.12.003_bib1075","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2169\/internalmedicine.51.6824","article-title":"Adult-onset Still's disease complicated by autoimmune hepatitis: successful treatment with infliximab","volume":"51","author":"Fujii","year":"2012","journal-title":"Intern Med Tokyo Jpn"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10067-009-1186-z","article-title":"An unusual case of autoimmune hepatitis in a patient with adult-onset Still's disease","volume":"29","author":"Xia","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib1085","first-page":"784","article-title":"Fulminant hepatic failure in adult onset Still's disease","volume":"23","author":"Dino","year":"1996","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.revmed.2019.12.003_bib1090","first-page":"2038","article-title":"Liver transplant in adult Still's disease","volume":"24","author":"McFarlane","year":"1997","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib1095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.revmed.2012.10.372","article-title":"[H\u00e9patite aigu\u00eb m\u00e9dicamenteuse \u00e0 l\u2019anakinra chez une patiente trait\u00e9e pour une maladie de Still de l\u2019adulte]","volume":"34","author":"Diallo","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2019.12.003_bib1100","first-page":"964828","article-title":"Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's Disease","volume":"2013","author":"Drepper","year":"2013","journal-title":"Case Rep Hepatol"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/acr.20319","article-title":"Tocilizumab in refractory adult Still's disease","volume":"63","author":"Pu\u00e9chal","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.revmed.2019.12.003_bib1110","unstructured":"J. Sibilia.. CRI-net: Fiches pratiques & eSessions SCRIPT: Fiches pratiques du CRI: Prise en charge pratique des patients sous. Tocilizumab [Jan. 2017] [Internet]. [2019]. Disponible sur: http:\/\/www.cri-net.com\/fiches-pratiques-et-eSessions\/dernieres-mises-a-jour\/prise-en-charge-pratique-des-patients-sous-tocilizumab."},{"issue":"12","key":"10.1016\/j.revmed.2019.12.003_bib1115","first-page":"527","article-title":"Hepatitis B-assocciated adult-onset Still's disease presenting with neutrophilic urticaria","volume":"8","author":"Gambichler","year":"2003","journal-title":"Eur J Med Res"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib1120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MD.0b013e3181a4d1a1","article-title":"Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24\u00a0patients","volume":"88","author":"Ben m\u2019rad","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib1125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00000441-200309000-00009","article-title":"Successful treatment with cyclosporin in adult-onset Still disease manifesting as acute hepatitis with marked hyperferritinemia","volume":"326","author":"Omagari","year":"2003","journal-title":"Am J Med Sci"},{"issue":"10","key":"10.1016\/j.revmed.2019.12.003_bib1130","first-page":"724","article-title":"Acute Severe Hepatitis and Hemophagocytosis in Adult Onset Still's Disease","volume":"18","author":"Sahutoglu","year":"2015","journal-title":"Arch Iran Med"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib1135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10067-007-0791-y","article-title":"Acute hepatitis in adult Still's disease during corticosteroid treatment successfully treated with anakinra","volume":"27","author":"Mylona","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/s10165-010-0365-8","article-title":"Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis","volume":"21","author":"Kishida","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib1145","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.revmed.2019.12.003_bib1150","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00296-016-3546-8","article-title":"Epidemiological study of adult-onset Still's disease using a Japanese administrative database","volume":"36","author":"Sakata","year":"2016","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semarthrit.2010.12.006","article-title":"The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76\u00a0Italian patients","volume":"41","author":"Colina","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.revmed.2019.12.003_bib1160","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00296-008-0813-3","article-title":"Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation","volume":"29","author":"Colina","year":"2009","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2177\/jsci.18.207","article-title":"A case of adult onset Still's disease complicated with adult respiratory distress syndrome and disseminated intravascular coagulation","volume":"18","author":"Yokoyama","year":"1995","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.revmed.2019.12.003_bib1170","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.12659\/AJCR.905684","article-title":"Extremely High Serum Ferritin: An Instrumental Marker of Masquerading Adult-Onset Still's Disease with Hemophagocytic Syndrome","volume":"18","author":"Yamashita","year":"2017","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.revmed.2019.12.003_bib1175","first-page":"128623","article-title":"An Unusual Case of Adult-Onset Still's Disease with Hemophagocytic Syndrome, Necrotic Leukoencephalopathy and Disseminated Intravascular Coagulation","volume":"2014","author":"Namas","year":"2014","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.revmed.2019.12.003_bib1180","first-page":"235","article-title":"Hypercoagulable states","volume":"35","author":"Moake","year":"1990","journal-title":"Adv Intern Med"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib1185","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/art.27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease","volume":"62","author":"Franchini","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib1190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10067-009-1097-z","article-title":"Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab","volume":"28","author":"Matsumoto","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3346\/jkms.2004.19.1.137","article-title":"Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A","volume":"19","author":"Park","year":"2004","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1200","first-page":"147","article-title":"[Cyclosporine therapy of adult onset Still's disease with disseminated intravascular coagulation]","volume":"34","author":"Mori","year":"1993","journal-title":"Rinsho Ketsueki"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib1205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semarthrit.2007.04.002","article-title":"Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature","volume":"37","author":"K\u00f6tter","year":"2007","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.revmed.2019.12.003_bib1210","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/art.24826","article-title":"Thrombotic microangiopathy and purtscher-like retinopathy associated with adult-onset Still's disease: a role for glomerular vascular endothelial growth factor?","volume":"61","author":"El Karoui","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.revmed.2019.12.003_bib1215","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10067-010-1418-2","article-title":"Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab","volume":"29","author":"Sumida","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib1220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MAJ.0b013e318191436e","article-title":"Thrombotic thrombocytopenic purpura and adult onset Still's disease","volume":"337","author":"Gopal","year":"2009","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib1225","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/rheumatology\/kel176","article-title":"Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura in the setting of adult-onset Still's disease","volume":"45","author":"Hirata","year":"2006","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib1230","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.transci.2013.02.040","article-title":"Complement alternative pathway activation in the course of thrombotic microangiopathy associated with adult-onset Still's disease","volume":"49","author":"Carron","year":"2013","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1235","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/09273948.2016.1213857","article-title":"A Rare Ocular Manifestation of Adult Onset Still's Disease: Purtscher's-like Retinopathy","volume":"26","author":"Buyukavsar","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1240","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/s10165-012-0650-9","article-title":"A case of adult-onset Still's disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema","volume":"23","author":"Masuyama","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"9","key":"10.1016\/j.revmed.2019.12.003_bib1245","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/rheumatology\/keu027","article-title":"Rituximab for refractory adult-onset Still's disease with thrombotic microangiopathy","volume":"53","author":"Lee","year":"2014","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00296-017-3854-7","article-title":"Cardiovascular disease in patients with autoinflammatory syndromes","volume":"38","author":"Hintenberger","year":"2018","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib1255","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s10067-015-3164-y","article-title":"A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?","volume":"35","author":"Dall\u2019Ara","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib1260","first-page":"807","article-title":"Pleuritis is a red flag for adult-onset Still's disease which may require biologic therapies","volume":"30","author":"Quartuccio","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.revmed.2019.12.003_bib1265","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11886-016-0727-8","article-title":"Recurrent Pericarditis: Modern Approach in 2016","volume":"18","author":"Imazio","year":"2016","journal-title":"Curr Cardiol Rep"},{"issue":"7","key":"10.1016\/j.revmed.2019.12.003_bib1270","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2169\/internalmedicine.9809-17","article-title":"Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A","volume":"57","author":"Kawaguchi","year":"2018","journal-title":"Intern Med Tokyo Jpn"},{"issue":"11","key":"10.1016\/j.revmed.2019.12.003_bib1275","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0248-8663(05)81400-6","article-title":"[Complications cardiaques de la maladie de Still de l\u2019adulte: de la p\u00e9ricardite \u00e0 la tamponade parfois r\u00e9v\u00e9latrice]","volume":"15","author":"Drouot","year":"1994","journal-title":"Rev Med Interne"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib1280","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/SMJ.0b013e3181ad4847","article-title":"Cardiac tamponade in Still disease: a review of the literature","volume":"102","author":"Parvez","year":"2009","journal-title":"South Med J"},{"issue":"17","key":"10.1016\/j.revmed.2019.12.003_bib1285","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MD.0000000000000112","article-title":"Myocarditis in adult-onset still disease","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 1","key":"10.1016\/j.revmed.2019.12.003_bib1290","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s10067-008-1010-1","article-title":"Multi-organ failure in adult onset Still's disease: a septic disguise","volume":"28","author":"Ames","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib1295","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14503\/THIJ-14-4101","article-title":"Adult-onset Still's disease and cardiac tamponade: a rare association","volume":"42","author":"Carrilho-Ferreira","year":"2015","journal-title":"Tex Heart Inst J"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1300","article-title":"Inadvertent Skipping of Steroids in Septic Shock Leads to a Diagnosis of Adult Onset Still's Disease","volume":"9","author":"Sethuraman","year":"2019","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.revmed.2019.12.003_bib1305","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1378\/chest.115.6.1738","article-title":"Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: clinical response with high-dose pulse methylprednisolone therapy","volume":"115","author":"Iglesias","year":"1999","journal-title":"Chest"},{"issue":"29","key":"10.1016\/j.revmed.2019.12.003_bib1310","doi-asserted-by":"crossref","first-page":"e7596","DOI":"10.1097\/MD.0000000000007596","article-title":"Tocilizumab for uncontrollable systemic inflammatory response syndrome complicating adult-onset Still disease: Case report and review of literature","volume":"96","author":"Masui-Ito","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib1315","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5114\/reum.2016.62476","article-title":"Limited diagnostic value of procalcitonin in early diagnosis of adult onset Still's disease","volume":"54","author":"Gowin","year":"2016","journal-title":"Reumatologia"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1320","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3899\/jrheum.110935","article-title":"A rare presentation of endocarditis in adult-onset Still's disease in diagnosis of fever of unknown origin","volume":"39","author":"Ertugrul","year":"2012","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.revmed.2019.12.003_bib1325","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.revmed.2018.04.016","article-title":"V\u00e9g\u00e9tation tricuspidienne au cours d\u2019une maladie de Still, une manifestation non infectieuse rare de l\u00e9sion intracardiaque","volume":"39","author":"Quelven","year":"2018","journal-title":"Rev Med Interne"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1330","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/14397595.2014.882220","article-title":"Complete atrioventricular block and aseptic meningitis in a patient with adult-onset Still's disease and concurrent hemophagocytic syndrome","volume":"25","author":"Tsuchiya","year":"2015","journal-title":"Mod Rheumatol"},{"issue":"30","key":"10.1016\/j.revmed.2019.12.003_bib1335","doi-asserted-by":"crossref","first-page":"e4258","DOI":"10.1097\/MD.0000000000004258","article-title":"Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature review","volume":"95","author":"Gerfaud-Valentin","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2019.12.003_bib1340","article-title":"Pulmonary arterial hypertension in adult-onset Still's disease: A case series and systematic review of the literature","author":"Narv\u00e1ez","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1345","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12890-016-0237-x","article-title":"Pulmonary arterial hypertension in adult onset Still's disease: a case report of a severe complication","volume":"16","author":"Guilleminault","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"17","key":"10.1016\/j.revmed.2019.12.003_bib1350","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1355","first-page":"177","article-title":"2015\u00a0ESC\/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension","volume":"69","author":"Gali\u00e8","year":"2016","journal-title":"Rev Espanola Cardiol Engl Ed"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib1360","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/2045893217712710","article-title":"Pulmonary arterial hypertension and acute respiratory distress syndrome in a patient with adult-onset stills disease","volume":"7","author":"Lowther","year":"2017","journal-title":"Pulm Circ"},{"key":"10.1016\/j.revmed.2019.12.003_bib1365","first-page":"537613","article-title":"Pulmonary Arterial Hypertension in Adult-Onset Still's Disease: Rapid Response to Anakinra","volume":"2012","author":"Campos","year":"2012","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.revmed.2019.12.003_bib1370","first-page":"27","article-title":"Pulmonary arterial hypertension secondary to adult-onset Still's disease: Response to cyclosporine and sildenafil over 15\u00a0years of follow-up","volume":"19","author":"Weatherald","year":"2016","journal-title":"Respir Med Case Rep"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib1375","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/1756-185X.12324","article-title":"A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6","volume":"17","author":"Kadavath","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib1380","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10067-006-0382-3","article-title":"Pulmonary hypertension in a patient with adult-onset Stills disease","volume":"26","author":"Mubashir","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3346\/jkms.2009.24.1.155","article-title":"A case of adult-onset Still's disease complicated with diffuse alveolar hemorrhage","volume":"24","author":"Sari","year":"2009","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib1390","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","article-title":"Life-threatening complications of adult-onset Still's disease","volume":"33","author":"Efthimiou","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1395","first-page":"88","article-title":"Bilateral empyema caused by adult-onset Still's disease","volume":"68","author":"Mattiuzzo","year":"2001","journal-title":"Respir Int Rev Thorac Dis"},{"issue":"47","key":"10.1016\/j.revmed.2019.12.003_bib1400","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1055\/s-2004-835297","article-title":"Disseminated intravascular coagulation, perimyocarditis and bilateral pleural empyema in adult Still's disease","volume":"129","author":"Krzossok","year":"2004","journal-title":"Dtsch Med Wochenschr 1946"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib1405","first-page":"833","article-title":"Amyloidosis in adult onset Still's disease","volume":"8","author":"Harrington","year":"1981","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1410","first-page":"373","article-title":"Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease","volume":"26","author":"Fautrel","year":"1999","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1415","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3904\/kjim.2000.15.2.131","article-title":"Secondary renal amyloidosis in adult onset Still's disease: case report and review of the literature","volume":"15","author":"Oh","year":"2000","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1420","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2169\/internalmedicine.32.50","article-title":"Systemic amyloidosis in a patient with adult onset Still's disease","volume":"32","author":"Ishii","year":"1993","journal-title":"Intern Med Tokyo Jpn"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1425","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02776678","article-title":"Improvement of endoscopic and histologic findings of AA-type gastrointestinal amyloidosis by treatment with dimethyl sulfoxide and prednisolone","volume":"20","author":"Takahashi","year":"1985","journal-title":"Gastroenterol Jpn"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib1430","first-page":"406","article-title":"Amylose au cours de la maladie de Still de l\u2019adulte. A propos de 2\u00a0observations","volume":"137","author":"Vigneron","year":"1986","journal-title":"Ann Med Interne (Paris)"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib1435","first-page":"630","article-title":"Secondary amylosis in Still's disease in an adult. Value of biopsy of the subcutaneous abdominal fatty tissue","volume":"55","author":"Horlait","year":"1988","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1440","first-page":"25","article-title":"A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases\u00a0\u2013\u00a0data from nationwide registries in Finland","volume":"18","author":"Immonen","year":"2011","journal-title":"Amyloid Int J Exp Clin Investig"},{"issue":"7","key":"10.1016\/j.revmed.2019.12.003_bib1445","first-page":"699","article-title":"Secondary bladder amyloidosis: a new case report","volume":"65","author":"Benito","year":"2012","journal-title":"Arch Esp Urol"},{"issue":"9275","key":"10.1016\/j.revmed.2019.12.003_bib1450","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet Lond Engl"},{"issue":"7","key":"10.1016\/j.revmed.2019.12.003_bib1455","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.amjmed.2003.04.001","article-title":"Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease","volume":"115","author":"Serratrice","year":"2003","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib1460","first-page":"907","article-title":"Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis","volume":"35","author":"Immonen","year":"2008","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib1465","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10067-005-0048-6","article-title":"Renal amyloidosis: an uncommon complication of juvenile idiopathic arthritis","volume":"25","author":"Duarte","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib1470","first-page":"178","article-title":"Rapid and sustained response to tocilizumab, anti-interleukin-6\u00a0receptor antibody, in a patient with nephrotic syndrome secondary to systemic juvenile idiopathic arthritis-related amyloidosis","volume":"4","author":"De La Torre","year":"2011","journal-title":"NDT Plus"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib1475","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12098-015-1913-1","article-title":"Systemic Juvenile Idiopathic Arthritis with Amyloidosis: An Uncommon Complication with a Favourable Outcome","volume":"83","author":"Sharma","year":"2016","journal-title":"Indian J Pediatr"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib1480","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00467-015-3249-5","article-title":"Anti-interleukin 1\u00a0treatment in secondary amyloidosis associated with autoinflammatory diseases","volume":"31","author":"Topaloglu","year":"2016","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1485","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12882-017-0573-y","article-title":"Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review","volume":"18","author":"Chantarogh","year":"2017","journal-title":"BMC Nephrol"},{"issue":"7","key":"10.1016\/j.revmed.2019.12.003_bib1490","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","article-title":"Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1495","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/ard.27.2.137","article-title":"Mortality and prognosis related to the amyloidosis of Still's disease","volume":"27","author":"Smith","year":"1968","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib1500","first-page":"1058","article-title":"Adult Still's disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.revmed.2019.12.003_bib1505","first-page":"1139","article-title":"Adult Still's disease: review of 228\u00a0cases from the literature","volume":"14","author":"Ohta","year":"1987","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib1510","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.autrev.2015.01.007","article-title":"Seizing the clinical presentation in adult onset Still's disease. An extensive literature review","volume":"14","author":"Narula","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib1515","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.54.5.1203","article-title":"Still's disease can cause neutrophilic meningitis","volume":"54","author":"Blockmans","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib1520","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.semarthrit.2010.05.003","article-title":"Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis-efficacy of interleukin-6\u00a0blockade and review of the literature","volume":"40","author":"Sabnis","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.revmed.2019.12.003_bib1525","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/rheumatology\/41.2.216","article-title":"Miller Fisher syndrome in adult onset Still's disease: case report and review of the literature of other neurological manifestations","volume":"41","author":"Desai","year":"2002","journal-title":"Rheumatol Oxf Engl"},{"issue":"10","key":"10.1016\/j.revmed.2019.12.003_bib1530","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2169\/internalmedicine.42.930","article-title":"Central nervous system involvement in adult onset still's disease","volume":"42","author":"Nagasawa","year":"2003","journal-title":"Intern Med Tokyo Jpn"},{"issue":"4","key":"10.1016\/j.revmed.2019.12.003_bib1535","first-page":"765","article-title":"Aseptic meningitis and focal central nervous system involvement in a case of adult onset Still's disease","volume":"20","author":"Garrote","year":"1993","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.revmed.2019.12.003_bib1540","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/ndt\/12.8.1714","article-title":"Vascular renal AA amyloidosis in adult Still's disease","volume":"12","author":"Rivera","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.revmed.2019.12.003_bib1545","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/sj.ki.5000352","article-title":"Nephrotic syndrome associated with hemophagocytic syndrome","volume":"69","author":"Thaunat","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib1550","first-page":"548","article-title":"Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany. Switzerland and Austria: results of a cross-sectional assessment conducted in 2012","volume":"34","author":"Akmatov","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2019.12.003_bib1555","first-page":"54","article-title":"Adult-onset Still's disease associated with collapsing glomerulopathy","volume":"3","author":"Arulkumaran","year":"2010","journal-title":"NDT Plus"},{"issue":"6","key":"10.1016\/j.revmed.2019.12.003_bib1560","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/rheumatology\/keh172","article-title":"Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil","volume":"43","author":"Bennett","year":"2004","journal-title":"Rheumatol Oxf Engl"},{"issue":"5","key":"10.1016\/j.revmed.2019.12.003_bib1565","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1053\/j.ajkd.2003.11.025","article-title":"Collapsing glomerulopathy in adult still's disease","volume":"43","author":"Kumar","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.revmed.2019.12.003_bib0785","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5152\/eurjrheumatol.2014.027","article-title":"An unusual manifestation in a patient with adult-onset Still's disease: Minimal glomerular lesion","volume":"1","author":"El Mezouar","year":"2014","journal-title":"Eur J Rheumatol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866319311798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866319311798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:42:26Z","timestamp":1759336946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866319311798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":157,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0248866319311798"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2019.12.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications de la maladie de Still de l\u2019adulte","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}